481 related articles for article (PubMed ID: 31884933)
1. Nano-Based Drug Delivery System: Recent Strategies for the Treatment of Ocular Disease and Future Perspective.
Qamar Z; Qizilbash FF; Iqubal MK; Ali A; Narang JK; Ali J; Baboota S
Recent Pat Drug Deliv Formul; 2019; 13(4):246-254. PubMed ID: 31884933
[TBL] [Abstract][Full Text] [Related]
2. Lipid nanocarriers (LNC) and their applications in ocular drug delivery.
Puglia C; Offerta A; Carbone C; Bonina F; Pignatello R; Puglisi G
Curr Med Chem; 2015; 22(13):1589-602. PubMed ID: 25666802
[TBL] [Abstract][Full Text] [Related]
3. A Mini-review on New Developments in Nanocarriers and Polymers for Ophthalmic Drug Delivery Strategies.
Sharma Y; Patel P; Kurmi BD
Curr Drug Deliv; 2024; 21(4):488-508. PubMed ID: 37143264
[TBL] [Abstract][Full Text] [Related]
4. Recent Advances in Ocular Drug Delivery, with Special Emphasis on Lipid Based Nanocarriers.
Sah AK; Suresh PK
Recent Pat Nanotechnol; 2015; 9(2):94-105. PubMed ID: 27009124
[TBL] [Abstract][Full Text] [Related]
5. Ophthalmic applications of lipid-based drug nanocarriers: an update of research and patenting activity.
Pignatello R; Carbone C; Puglia C; Offerta A; Bonina FP; Puglisi G
Ther Deliv; 2015; 6(11):1297-318. PubMed ID: 26608630
[TBL] [Abstract][Full Text] [Related]
6. Fostering the unleashing potential of nanocarriers-mediated delivery of ocular therapeutics.
Datta D; Priyanka Bandi S; Colaco V; Dhas N; Siva Reddy DV; Vora LK
Int J Pharm; 2024 Jun; 658():124192. PubMed ID: 38703931
[TBL] [Abstract][Full Text] [Related]
7. Applications of Nanotechnology-mediated Herbal Nanosystems for Ophthalmic Drug.
Shree D; Patra CN; Sahoo BM
Pharm Nanotechnol; 2024; 12(3):229-250. PubMed ID: 37587812
[TBL] [Abstract][Full Text] [Related]
8. Recent advance of nanoparticle-based topical drug delivery to the posterior segment of the eye.
Wang Y; Xu X; Gu Y; Cheng Y; Cao F
Expert Opin Drug Deliv; 2018 Jul; 15(7):687-701. PubMed ID: 29985660
[TBL] [Abstract][Full Text] [Related]
9. Application of lipid nanoparticles to ocular drug delivery.
Battaglia L; Serpe L; Foglietta F; Muntoni E; Gallarate M; Del Pozo Rodriguez A; Solinis MA
Expert Opin Drug Deliv; 2016 Dec; 13(12):1743-1757. PubMed ID: 27291069
[TBL] [Abstract][Full Text] [Related]
10. Dendrimer nanoparticles for ocular drug delivery.
Kambhampati SP; Kannan RM
J Ocul Pharmacol Ther; 2013 Mar; 29(2):151-65. PubMed ID: 23410062
[TBL] [Abstract][Full Text] [Related]
11. Ophthalmic nano-bioconjugates: critical challenges and technological advances.
Sanap SN; Bisen AC; Agrawal S; Kedar A; Bhatta RS
Ther Deliv; 2023 Jul; 14(7):419-441. PubMed ID: 37535389
[TBL] [Abstract][Full Text] [Related]
12. Emphasis on Nanostructured Lipid Carriers in the Ocular Delivery of Antibiotics.
Singh CP; Rai PK; Kumar M; Tiwari V; Tiwari A; Sharma A; Sharma K
Pharm Nanotechnol; 2024; 12(2):126-142. PubMed ID: 37519002
[TBL] [Abstract][Full Text] [Related]
13. Nanoparticles in Ocular Drug Delivery Systems for Topical Administration: Promises and Challenges.
Almeida H; Amaral MH; Lobao P; Frigerio C; Sousa Lobo JM
Curr Pharm Des; 2015; 21(36):5212-24. PubMed ID: 26412360
[TBL] [Abstract][Full Text] [Related]
14. Potential enhancement and targeting strategies of polymeric and lipid-based nanocarriers in dermal drug delivery.
Kahraman E; Güngör S; Özsoy Y
Ther Deliv; 2017 Nov; 8(11):967-985. PubMed ID: 29061106
[TBL] [Abstract][Full Text] [Related]
15. Fundamentals, challenges, and nanomedicine-based solutions for ocular diseases.
Srinivasarao DA; Lohiya G; Katti DS
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 Jul; 11(4):e1548. PubMed ID: 30506871
[TBL] [Abstract][Full Text] [Related]
16. Polysaccharide-Based Nanocarriers for Ocular Drug Delivery.
Formica ML; Calles JA; Palma SD
Curr Pharm Des; 2015; 21(33):4851-68. PubMed ID: 26290208
[TBL] [Abstract][Full Text] [Related]
17. Recent Techniques and Patents on Solid Lipid Nanoparticles as Novel Carrier for Drug Delivery.
Khatak S; Dureja H
Recent Pat Nanotechnol; 2015; 9(3):150-77. PubMed ID: 27009132
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in ocular drug delivery.
Achouri D; Alhanout K; Piccerelle P; Andrieu V
Drug Dev Ind Pharm; 2013 Nov; 39(11):1599-617. PubMed ID: 23153114
[TBL] [Abstract][Full Text] [Related]
19. Patent perspectives for corticosteroids based ophthalmic therapeutics.
Suresh PK; Sah AK
Recent Pat Drug Deliv Formul; 2014; 8(3):206-23. PubMed ID: 25020063
[TBL] [Abstract][Full Text] [Related]
20. A review of nanocarrier-mediated drug delivery systems for posterior segment eye disease: challenges analysis and recent advances.
Wang R; Gao Y; Liu A; Zhai G
J Drug Target; 2021 Aug; 29(7):687-702. PubMed ID: 33474998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
